We represented SAI-Med Partners, a portfolio company of Northlane Capital Partners and a global consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries, in its acquisition of The Dunn Group, a competitive intelligence firm that focuses on providing primary business intelligence to clients.